The rising interest in GLP-1 agonists for metabolic conditions has generated a question about formats: transdermal systems versus pills . Traditionally , GLP-1 treatments were solely available in oral form, but the introduction of transdermal delivery presents a alternative choice . Skin applications might benefit individuals experiencing issues… Read More